S100A16 and adenocarcinoma: On the contrary, in oral squamous carcinoma, the prognosis was better for patients with high S100A16 expression [10] suggesting that S100A16 had different buffering or inhibitory functions in adenocarcinoma and squamous carcinoma in an expression-dependent manner.